Business Description
Caribou Biosciences Inc
NAICS : 541713
SIC : 2833
ISIN : US1420381089
Share Class Description:
CRBU: Ordinary SharesDescription
Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies.
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 10.83 | |||||
Equity-to-Asset | 0.84 | |||||
Debt-to-Equity | 0.08 | |||||
Debt-to-EBITDA | -0.21 | |||||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 0.15 | |||||
Beneish M-Score | -2.32 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 1.5 | |||||
3-Year EBITDA Growth Rate | -6.2 | |||||
3-Year EPS without NRI Growth Rate | -4.3 | |||||
3-Year FCF Growth Rate | -4.4 | |||||
Future 3-5Y EPS without NRI Growth Rate | 14.5 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 31.81 | |||||
9-Day RSI | 28.39 | |||||
14-Day RSI | 25.87 | |||||
6-1 Month Momentum % | -58.75 | |||||
12-1 Month Momentum % | -47.43 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 10.49 | |||||
Quick Ratio | 10.49 | |||||
Cash Ratio | 10.13 | |||||
Days Sales Outstanding | 9.83 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -47.3 | |||||
Shareholder Yield % | -112.4 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -392 | |||||
Net Margin % | -345.05 | |||||
FCF Margin % | -344.52 | |||||
ROE % | -34.77 | |||||
ROA % | -28.91 | |||||
ROIC % | -115.64 | |||||
ROC (Joel Greenblatt) % | -334.81 | |||||
ROCE % | -35.38 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 3.9 | |||||
PB Ratio | 0.42 | |||||
Price-to-Tangible-Book | 0.42 | |||||
EV-to-EBIT | 0.93 | |||||
EV-to-EBITDA | 0.96 | |||||
EV-to-Revenue | -3.66 | |||||
EV-to-Forward-Revenue | 0.21 | |||||
EV-to-FCF | 1.06 | |||||
Price-to-Net-Current-Asset-Value | 0.6 | |||||
Price-to-Net-Cash | 0.63 | |||||
Earnings Yield (Greenblatt) % | 107.53 | |||||
FCF Yield % | -79.64 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:CRBU
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Caribou Biosciences Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 33.404 | ||
EPS (TTM) ($) | -1.46 | ||
Beta | 2.26 | ||
Volatility % | 128.22 | ||
14-Day RSI | 25.87 | ||
14-Day ATR ($) | 0.16841 | ||
20-Day SMA ($) | 1.793 | ||
12-1 Month Momentum % | -47.43 | ||
52-Week Range ($) | 1.535 - 8.5899 | ||
Shares Outstanding (Mil) | 90.32 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Caribou Biosciences Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Caribou Biosciences Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Caribou Biosciences Inc Frequently Asked Questions
What is Caribou Biosciences Inc(CRBU)'s stock price today?
The current price of CRBU is $1.60. The 52 week high of CRBU is $8.59 and 52 week low is $1.54.
When is next earnings date of Caribou Biosciences Inc(CRBU)?
The next earnings date of Caribou Biosciences Inc(CRBU) is 2024-08-08 Est..
Does Caribou Biosciences Inc(CRBU) pay dividends? If so, how much?
Caribou Biosciences Inc(CRBU) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |